Dr. Emily Rogalski leads a research lab at the University of Chicago focused on understanding cognitive resilience in aging and improving communication for individuals with neurological conditions. Her work aims to identify factors that contribute to exceptional cognitive performance in older adults, particularly those who are 'SuperAgers.' Additionally, she develops interventions to enhance the quality of life for patients with primary progressive aphasia, exploring both clinical trials and community-based solutions.

Dr. Christopher Manuel Gomez's lab at the University of Chicago focuses on understanding calcium channel gene disorders, which often lead to severe neurological issues. Their research delves into how mutations in these genes can result in different neuronal outcomes by studying the dual role of calcium channel genes—both as channel proteins and newly discovered transcription factors. The lab aims to develop innovative therapies that target the underlying biological mechanisms of these disorders.

Dr. Tao Xie's lab at the University of Chicago focuses on understanding the relationship between gut bacteria and Parkinson's disease (PD). The research aims to explore how changes in gut microbiota might influence the onset and progression of PD symptoms. The team conducts both cross-sectional and longitudinal studies on diverse patient populations, emphasizing the underrepresented Black community. Through advanced techniques, the lab aims to identify potential biomarkers for diagnosis and novel interventions for treating Parkinson's disease.

Dr. Joel Voss's lab at the University of Chicago focuses on understanding how the human hippocampus contributes to forming and retrieving memories. By studying individuals with epilepsy and using advanced brain recording techniques, the lab investigates the brain's mechanisms during memory formation processes, especially regarding how memory is influenced by visual sampling. Their work aims to uncover insights that could lead to new treatments for memory-related disorders.

Dr. Shyam Prabhakaran's research focuses on improving the emergency evaluation and transfer processes for stroke patients. His lab conducts studies that aim to enhance the Door-In-Door-Out (DIDO) protocol to ensure patients get timely access to comprehensive stroke care. Through interdisciplinary collaboration, the lab seeks to develop and implement effective strategies that can reduce delays in treatment and improve outcomes for stroke patients nationwide.